Literature DB >> 31646293

Cardiovascular disease in type 1 diabetes: the elephant in the clinic.

John R Petrie1.   

Abstract

Entities:  

Year:  2019        PMID: 31646293      PMCID: PMC6739892          DOI: 10.1097/XCE.0000000000000170

Source DB:  PubMed          Journal:  Cardiovasc Endocrinol Metab        ISSN: 2574-0954


× No keyword cloud information.
  4 in total

Review 1.  10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2019.

Authors: 
Journal:  Diabetes Care       Date:  2019-01       Impact factor: 19.112

2.  Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial.

Authors:  John R Petrie; Nishi Chaturvedi; Ian Ford; Martijn C G J Brouwers; Nicola Greenlaw; Therese Tillin; Irene Hramiak; Alun D Hughes; Alicia J Jenkins; Barbara E K Klein; Ronald Klein; Teik C Ooi; Peter Rossing; Coen D A Stehouwer; Naveed Sattar; Helen M Colhoun
Journal:  Lancet Diabetes Endocrinol       Date:  2017-06-11       Impact factor: 32.069

3.  Update on cardiovascular outcomes at 30 years of the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.

Authors:  John M Lachin; Trevor J Orchard; David M Nathan
Journal:  Diabetes Care       Date:  2014       Impact factor: 19.112

4.  Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From a Diabetes Care Editors' Expert Forum.

Authors:  William T Cefalu; Sanjay Kaul; Hertzel C Gerstein; Rury R Holman; Bernard Zinman; Jay S Skyler; Jennifer B Green; John B Buse; Silvio E Inzucchi; Lawrence A Leiter; Itamar Raz; Julio Rosenstock; Matthew C Riddle
Journal:  Diabetes Care       Date:  2018-01       Impact factor: 19.112

  4 in total
  1 in total

1.  Cardiometabolic medicine: time to recognize a new clinical specialty?

Authors:  Andrew J Krentz; Stephan Jacob
Journal:  Cardiovasc Endocrinol Metab       Date:  2019-05-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.